Gait Disturbances and Hips Bone Mineral Density

This study is not yet open for participant recruitment.

Verified March 2012 by Tel-Aviv Sourasky Medical Center

Sponsor:

Information provided by (Responsible Party):

Tel-Aviv Sourasky Medical Center

ClinicalTrials.gov Identifier:

NCT01554605

First received: February 23, 2012

Last updated: March 14, 2012

Last verified: March 2012

History of Changes

Tracking Information
First Received Date ^ICMJE	February 23, 2012
Last Updated Date	March 14, 2012
Start Date ^ICMJE	March 2012
Primary Completion Date	Not Provided
Current Primary Outcome Measures ^ICMJE	Not Provided
Original Primary Outcome Measures ^ICMJE	Not Provided
Change History	Complete list of historical versions of study NCT01554605 on ClinicalTrials.gov Archive Site
Current Secondary Outcome Measures ^ICMJE	Not Provided
Original Secondary Outcome Measures ^ICMJE	Not Provided
Current Other Outcome Measures ^ICMJE	Not Provided
Original Other Outcome Measures ^ICMJE	Not Provided

Descriptive Information
Brief Title ^ICMJE	Gait Disturbances and Hips Bone Mineral Density
Official Title ^ICMJE	Not Provided
Brief Summary	The objective of this study is to investigate the role of gait disturbance as a cause for difference in Bone Mineral Density (BMD) between both hips. Each subject will undergo the following tests: Functional Mobility Testing, Gait analysis, Motion Analysis, Assessments for Balance and Gait and Cognitive assessments.
Detailed Description	Not Provided
Study Type ^ICMJE	Observational
Study Design ^ICMJE	Observational Model: Case-Crossover Time Perspective: Prospective
Target Follow-Up Duration	Not Provided
Biospecimen	Not Provided
Sampling Method	Probability Sample
Study Population	subjects will be recruited from the bone clinic
Condition ^ICMJE	Difference in BMD Between Both Hips
Intervention ^ICMJE	Not Provided
Study Group/Cohort (s)	Not Provided
Publications *	Not Provided
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.

Recruitment Information
Recruitment Status ^ICMJE	Not yet recruiting
Estimated Enrollment ^ICMJE	40
Completion Date	Not Provided
Primary Completion Date	Not Provided
Eligibility Criteria ^ICMJE	Inclusion Criteria: differeneces in hips in Bone Mineral Density test in one group. Age 40-80. Exclusion Criteria: bone disease, arthritis, congenital skeletal malformations, pregnancy, neurological disease
Gender	Both
Ages	40 Years to 80 Years
Accepts Healthy Volunteers	Yes
Contacts ^ICMJE	Not Provided
Location Countries ^ICMJE	Not Provided

Administrative Information
NCT Number ^ICMJE	NCT01554605
Other Study ID Numbers ^ICMJE	TASMC-12-NV-648-CTIL
Has Data Monitoring Committee	Not Provided
Responsible Party	Tel-Aviv Sourasky Medical Center
Study Sponsor ^ICMJE	Tel-Aviv Sourasky Medical Center
Collaborators ^ICMJE	Not Provided
Investigators ^ICMJE	Not Provided
Information Provided By	Tel-Aviv Sourasky Medical Center
Verification Date	March 2012
^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP

To Top